ARTA
NXTM

A.R.T. Advisors’s NxStage Medical Inc. NXTM Stock Holding History

A.R.T. Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-37,600
Closed -$985K – 1866
2016
Q4 		$985K Buy
+37,600
New +$930K 0.06% 489
2016
Q3 		– Sell
-62,501
Closed -$1.35M – 1429
2016
Q2 		$1.35M Buy
62,501
+50,590
+425% +$903K 0.07% 432
2016
Q1 		$178K Sell
11,911
-66,800
-85% -$1.12M 0.01% 1194
2015
Q4 		$1.72M Sell
78,711
-69,261
-47% -$1.29M 0.08% 340
2015
Q3 		$2.33M Buy
147,972
+96,696
+189% +$1.55M 0.09% 334
2015
Q2 		$732K Buy
+51,276
New +$868K 0.02% 842
2013
Q3 		– Sell
-19,322
Closed -$275K – 1597
2013
Q2 		$275K Buy
+19,322
New +$243K 0.01% 1065

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

A.R.T. Advisors's NXTM Position: Q1 2017 in Review

A.R.T. Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 37,600 shares — an estimated $985K sold.

A.R.T. Advisors first reported a position in NXTM in Q2 2013 and held it in 7 quarters. The position peaked at $2.33M in Q3 2015. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • A.R.T. Advisors reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 37,600 NxStage Medical Inc. shares in Q1 2017, an estimated $985K.
  • A.R.T. Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 7 quarters.
  • A.R.T. Advisors's NxStage Medical Inc. position peaked at $2.33M in Q3 2015.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on A.R.T. Advisors's 13F filing for Q1 2017, filed 15 May 2017.